Drug LitigationCosts of Transvaginal Mesh Operation May Not Exceed Benefits

August 27, 2012

When consumers make decisions, they typically weigh the costs of a purchase against its benefits. Whether you’re purchasing a $4 gallon of milk or a $4,000 surgical procedure, the decision-making process is the same. For this reason, of course, it’s important that consumers know the price of what they’re purchasing – including the service’s risk.

 

Tragically, recent reports from the Food and Drug Administration (FDA) suggest that the makers of transvaginal mesh devices, medical products commonly used to treat pelvic organ prolapse (POP) and stress urinary incontinence (SUI), may not have given patients and health care providers sufficient information about the risks of their product.

 

Did you experience unusual pain or discomfort following your transvaginal mesh operation? Your rights to good health care and informed decision-making may have been violated as a result – and you may have a legal claim to compensation. Find out what you need to know by contacting the dedicated professionals at Nachawati Law Group. We can help.

———

About Nachawati Law Group
Nachawati Law Group represents parties in mass tort litigation, businesses and governmental entities in contingent litigation, and individuals in complex personal injury litigation. For more information, visit contact [email protected] or call 214-890-0711.